Actively Recruiting
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
Led by Brigham and Women's Hospital · Updated on 2026-01-05
120
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
Sponsors
B
Brigham and Women's Hospital
Lead Sponsor
N
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.
CONDITIONS
Official Title
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Rheumatoid arthritis diagnosed by a rheumatologist
- Age between 40 and 79 years
- At least one atherosclerotic cardiovascular disease risk factor, including prediabetes, hypertension, BMI greater than 30, or current or past cigarette smoking
You will not qualify if you...
- Currently taking statins, cholesterol absorption inhibitors, or PCSK9 inhibitors, or have a contraindication to statins
- Diagnosis of diabetes mellitus
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Brigham and Womens Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here